The Food and Drug Administration (FDA) is seeking approval for a brand name acquisition of American National Standards Institute (ANSI) membership, justified under Federal Acquisition Regulations (FAR) 13.501(a)(1)(ii) for sole source/brand name procurements. This membership is crucial for the FDA's Center for Devices & Radiological Health (CDRH) to maintain access to medical device standards, participate in standards development committees (e.g., USNC US TAG IEC TC77, ISO TC 338 TAG), and fulfill its regulatory responsibilities in approving medical device premarket applications. ANSI is identified as the sole organization capable of providing these services due to its exclusive designation as the U.S. National Standards Body and its unique role in accrediting U.S.-based standards organizations, ensuring FDA's continued participation in critical national and international standards activities.
The FDA is issuing a Request for Purchase Order (PO) to renew its American National Standards Institute (ANSI) Standards Membership, identified by Solicitation Number 75F40126Q00014. Interested contractors must submit a fixed-price quote to Brian Wodzisz via email by 3:00 PM Eastern Time on December 30th, 2025. Quotes must be valid for 60 days, submitted in an unsecured format, and include an itemized list with product descriptions, part numbers, and any assumptions. Partial or incomplete quotes will not be considered. The government will evaluate quotes based on total price and technical features meeting or exceeding requirements, with the intent to award a purchase order without discussions. The Statement of Work (SOW) is attached for reference.
The U.S. Food and Drug Administration (FDA) has issued a combined synopsis/solicitation (75F40126Q00014) for a Brand Name American National Standards Institute (ANSI) Standards Membership. This Request for Quotation (RFQ) seeks a commercial item, firm fixed-price purchase order for unlimited FDA user access to ANSI standards for a base year and four option years, spanning from January 21, 2026, to January 20, 2031. The FDA utilizes these standards for regulatory purposes, particularly in medical devices. The membership must provide 24/7 access, support standards policy development, and offer specialized conformity assessment programs. Quotes will be evaluated based on the lowest price technically acceptable criteria, ensuring compliance with technical capabilities, period of performance, and pricing for all line items. Offerors must submit quotes by December 30, 2025, by 3:00 PM ET, and adhere to specific invoicing instructions via the Invoice Processing Platform (IPP) and accessibility standards for Information and Communication Technology (ICT).